
Neuroimmune Crosstalk and Inflammation in Chemotherapy-induced Peripheral Neuropathy
Chemotherapy-induced peripheral neuropathy (CIPN) is increasingly recognized as more than a direct neurotoxic injury. Emerging research suggests that complex interactions between the nervous system an...
11 Aug 25min

Clinical Translation and Symptom Management in Chemotherapy Induced Peripheral Neuropathy
Chemotherapy-induced peripheral neuropathy (CIPN) remains one of the most common and challenging complications of cancer treatment. While significant progress has been made in understanding the condit...
7 Juli 14min

Precision Medicine: Biomarkers and Risk Prediction in Chemotherapy Induced Peripheral Neuropathy
Why do some patients develop severe chemotherapy-induced peripheral neuropathy (CIPN) while others receiving the same treatment experience little or no nerve damage? In this episode, Drs. Paola Albert...
9 Juni 24min

Neurotoxicity and Chemotherapy - An Oncology Perspective
In this episode of the Peripheral Nerve Podcast, hosts Susanna Park and Paola Alberti are joined by Maryam Lustberg to explore the real-world impact of chemotherapy-induced peripheral neuropathy (CIPN...
12 Maj 16min

Cellular and Molecular Mechanisms of Chemotherapy Induced Peripheral Neuropathy Pathophysiology
In this episode of the Peripheral Nerve Podcast, hosts Dr. Paola Alberti (University of Milano-Bicocca, Italy) and Professor Susanna Park (University of Sydney, Australia) are joined by Professor Guid...
14 Apr 15min

Treatment, Prognosis, Prevention
In this concluding episode of the Peripheral Nerve Society's Leprosy Awareness Podcast series, global experts examine the critical reality that microbiologic cure does not equal patient recovery. The ...
19 Feb 46min

Pathology and imaging methods in leprosy neuropathy
In this episode of the Leprosy Awareness Podcast, we tackle one of the most complex challenges in clinical practice: accurate and timely diagnosis of leprosy neuropathy. This episode explores how neur...
13 Jan 48min

















